IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS

Clinical trials for IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS explained in plain language.

Never miss a new study

Get alerted when new IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS trials appear

Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Trial aims to tame debilitating side effect of powerful cancer drugs

Disease control Terminated

This study aimed to see if adding a drug called etrasimod to standard steroid treatment could better control severe diarrhea and colon inflammation (colitis) caused by cancer immunotherapy. It planned to enroll adults with advanced cancer who developed this serious side effect wh…

Matched conditions: IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS

Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control

Last updated Apr 04, 2026 10:05 UTC

IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS

Get alerted when new IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS trials appear

Trial aims to tame debilitating side effect of powerful cancer drugs